Journal
PEDIATRIC BLOOD & CANCER
Volume 51, Issue 6, Pages 828-831Publisher
WILEY-LISS
DOI: 10.1002/pbc.21594
Keywords
fluorine-18-fluorodeoxyglucose; I123-MIBG; neuroblastoma; positron emission tomography
Categories
Ask authors/readers for more resources
We report on the case of a 10-month-old female infant with a metastatic neuroblastoma which became MIBG-negative at time of relapse. We discuss the different hypothesis associated with this particular outcome, and the potential utility of FDG-PET as an alternative to follow up the residual disease at this stage. Pediatr Blood Cancer 2008;51:828-831. (C) 2008 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
